The androgen receptor (AR) is important in prostate cancer and BAG-1 increases sensitivity of AR expressing cells to androgens and decreases sensitivity to cyproterone acetate, an anti-androgen used clinically in the treatment of prostate cancer (Froesch et al, 1998). The gene discussed is AR; the disease is prostate carcinoma.